Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance

María‐Victoria Mateos, Jesús F. San Miguel, María-Luisa Martín-Ramos et al.|Blood|2011

Cited by 58